We are live on ! Find out more
OPK icon

Opko Health

245 hedge funds and large institutions have $1.05B invested in Opko Health in 2017 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 74 increasing their positions, 70 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 70

0.38% less ownership

Funds ownership: 23.91%23.53% (-0.38%)

4% less funds holding

Funds holding: 256245 (-11)

11% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 36

15% less capital invested

Capital invested by funds: $1.24B → $1.05B (-$193M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

65% less call options, than puts

Call options by funds: $25M | Put options by funds: $71.2M

Holders
245
Holders Change
-11
Holders Change %
-4.3%
% of All Funds
6.1%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
32
Increased
74
Reduced
70
Closed
36
Calls
$25M
Puts
$71.2M
Net Calls
-$46.2M
Net Calls Change
-$32.4M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$211M +$9.37M +1,112,843 +4%
BlackRock
2
BlackRock
New York
$181M +$189M +22,449,752 +11,481%
State Street
3
State Street
Massachusetts
$87.4M +$26.4M +3,138,685 +40%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$45.8M -$22.6M -2,679,462 -32%
MTWSIF
5
Mivtachim The Workers Social Insurance Fund
Israel
$40.5M +$16.4M +1,944,549 +62%
Bank of America
6
Bank of America
North Carolina
$30.8M +$4.51M +535,784 +16%
OIM
7
Oracle Investment Management
Connecticut
$28.3M -$13K -1,539 -0%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$23.1M +$1.77M +210,736 +8%
Morgan Stanley
9
Morgan Stanley
New York
$22.3M -$16M -1,898,756 -41%
Norges Bank
10
Norges Bank
Norway
$20M -$6.48M -770,208 -24%
Goldman Sachs
11
Goldman Sachs
New York
$18.9M +$4.72M +561,158 +31%
HIIFS
12
Harel Insurance Investments & Financial Services
Israel
$18.8M +$732K +86,989 +4%
Northern Trust
13
Northern Trust
Illinois
$13.7M +$2.4M +285,621 +20%
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
$13M +$263K +31,225 +2%
BM
15
Bridger Management
New York
$12.2M
IA
16
IFP Advisors
Florida
$11.6M +$3.34M +396,884 +38%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$10.8M -$504K -59,882 -4%
WMSA
18
Weiss Multi-Strategy Advisers
New York
$9.6M +$3.49M +414,685 +53%
MMH
19
Menora Mivtachim Holdings
Israel
$9.13M -$18.5M -2,198,900 -66%
Bank of Montreal
20
Bank of Montreal
Ontario, Canada
$8.36M -$4.2M -498,841 -32%
Group One Trading
21
Group One Trading
Illinois
$8.19M -$1.32M -156,381 -13%
T. Rowe Price Associates
22
T. Rowe Price Associates
Maryland
$7.81M +$736K +87,362 +10%
TCIM
23
TIAA CREF Investment Management
New York
$7.78M -$282K -33,537 -3%
Invesco
24
Invesco
Georgia
$7.4M +$2M +238,032 +35%
Charles Schwab
25
Charles Schwab
California
$7.25M -$314K -37,309 -4%

OPK Hedge Fund Activity: Q1 2017 in Review

245 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Opko Health (OPK) for Q1 2017, worth a combined $1.05B — down 15% from $1.24B a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of OPK and 32 opened new positions — a net loss of 4 holders — while 70 trimmed existing stakes and 74 added.

The largest buyer was BlackRock, adding an estimated $189M. The largest seller was Fidelity Investments, cutting an estimated $22.6M.

  • 245 institutional investors held Opko Health (OPK) as of Q1 2017, down from 256 in Q4 2016.
  • Funds reported $1.05B of Opko Health stock for Q1 2017, down 15% quarter-over-quarter.
  • 32 funds opened new Opko Health positions in Q1 2017 and 36 closed out, a net change of -4 holders.
  • The largest Opko Health buyer in Q1 2017 was BlackRock, an estimated $189M added.
  • The largest Opko Health seller in Q1 2017 was Fidelity Investments, an estimated $22.6M sold.

Based on aggregated 13F filings for Q1 2017.